SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001610618-24-000043
Filing Date
2024-04-22
Accepted
2024-04-22 17:18:01
Documents
17
Period of Report
2024-04-22
Items
Item 2.02: Results of Operations and Financial Condition
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CIDARA THERAPEUTICS, INC. FORM 8-K cdtx-20240422.htm   iXBRL 8-K 35195
2 EARNINGS RELEASE ex991-2024x04x22.htm EX-99.1 74030
3 PRESS RELEASE ex992-2024x04x22.htm EX-99.2 11292
7 GRAPHIC cidaralogo.jpg GRAPHIC 63449
8 GRAPHIC cidaralogoa.jpg GRAPHIC 63449
  Complete submission text file 0001610618-24-000043.txt   442324

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cdtx-20240422.xsd EX-101.SCH 1899
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cdtx-20240422_lab.xml EX-101.LAB 23707
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cdtx-20240422_pre.xml EX-101.PRE 13583
20 EXTRACTED XBRL INSTANCE DOCUMENT cdtx-20240422_htm.xml XML 2929
Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Filer) CIK: 0001610618 (see all company filings)

IRS No.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36912 | Film No.: 24862038
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)